Pmu55 - Consequences on Economic Outcomes of Generic Versus Brand-Name Drugs Used in Routine Clinical Practice: The Case of Treating Peripheral Neuropathic Pain or Generalized Anxiety Disorder With Pregabalin

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1891
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy92 - Economic and Patient Outcomes of Generic and Brand-Name Statins Used in Routine Clinical Practice in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Cost-Consequences Analysis of the Effect of Pregabalin in the Treatment of Peripheral Neuropathic Pain in Routine Medical Practice in Primary Care Settings

BMC Neurology
MedicineNeurology
2011English

The Concept Of: Generic Drugs and Patented Drugs vs. Brand Name Drugs and Non-Proprietary (Generic) Name Drugs

Frontiers in Pharmacology
Pharmacology
2013English

Brand-Name Versus Generic: The Authors Respond

Health Affairs
MedicineHealth Policy
2007English

Pharmacotherapy Update: Pregabalin in the Treatment of Generalized Anxiety Disorder

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Brand Name or Generic Drugs: A National Survey of Patient Perception and Preferences

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Treatment Persistence and Adherence and Their Consequences on Patient Outcomes of Generic Versus Brand-Name Statins Routinely Used to Treat High Cholesterol Levels in Spain: A Retrospective Cost-Consequences Analysis

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2018English

Pregabalin: Dose-Response Relationship in Generalized Anxiety Disorder

Pharmacopsychiatry
MedicinePsychiatryMental HealthPharmacology
2011English

Meta-Analysis of Duloxetine vs. Pregabalin and Gabapentin in the Treatment of Diabetic Peripheral Neuropathic Pain

BMC Neurology
MedicineNeurology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy